维普中文期刊产品整合服务
43篇 您的检索式:作者名="Awada H"
    题名 作者 年代 出处 被引量
1Pooled analysis of BAY 43-92006 (sorafenib) monotherapy in patients with advanced solid turnouts: is rash associated with treat- ment outcome? 显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,4:1
2Pooled safety analysis of BAY 43 - 9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? 显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,:1
3Sialyl lewis (x) (CD15s)monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation显示文摘 Koyama I Awada T 2000Transplantation2000,69,10:1
4Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis 显示文摘Awada H Barlowatz-Meimon G Dougados M 1988J Lab Clin Med1988,111,2:1
5Pooled safety analy- sis of BAY 43-9006 (sorafenib)monotherapy in patients with advanced solid tumours:Is rash associat-ed with treatment out- come显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,4:1
6Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures 显示文摘Arabi A Baddoura R Awada H 2007Bone2007,40,:1
7Stomata variability of native warm-season grasses from the Nebraska Sandhills显示文摘Awada T Moser L E Schacht W H 2002Canadian Journal of Plant Science2002,82,2:1
8Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumors:Is rash associated with treatment outcome显示文摘Strumberg D Awada A Hirte H 0,,04:1
9Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anticancer agents: a review of clinical trials 显示文摘TAKIMOTO C H AWADA A 2008Can Chem Phar-maco2008,61,4:1
10Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials 显示文摘TAKIMOTO C H AWADA A 2008Cancer Chemother Pharmacol2008,61,4:1
11Progressive paraparesis with sensorineural deafness and leukoencephalopathy revealing neurobrucellosis显示文摘Awada A Korri H Issa Z 2011Rev Neurol(Paris)2011,167,:1
12Pooled safety analysis of BAY 43-9006 ( sorafenib ) monotherapy in patients with advanced solid tumours:Is rash associated with treatment outcome? 显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,4:1
13Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? 显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,4:1
14Pooled safety analysis of BAY43-9006 (sorafenib) monotherapy in patients with advanced solid tumours:Is rash associated with treatment outeome?显示文摘Strumberg D Awada A Hirte H 0,,04:1
15Pooled safety analysis of BAY43-9006 (sorafenib) monotherapy in patients with advanced solid tumors:is rash associated with treatment outcome显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,:1
16New therapeutic developments in renal cell cancer显示文摘Prenen H Gil T Awada A 0,,01:1
17New therapeutic developments in renal cell cancer 显示文摘Prenen H Gil T Awada A 2009Crit Rev Oncol Hematol2009,69,1:1
18Pooled safety analysis of BAY 43--9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment out come 显示文摘Strumberg D Awada A Hirte H 2006Eur J Cancer2006,42,4:1
19Basolateral secretion of WntSa in polarized epithelial cells is required for apical lumen formation显示文摘Yamamotol H Awada C Matsumoto S 2015J Cell Science2015,128,5:1
20Cardiac troponin T:a useful early marker for cardiac and respiratory dysfunction in neonates显示文摘Awada H Al-Tannir M Ziade MF 2007Neonatology2007,92,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费